…with relapsing-remitting MS (Freedman et al. Can J Neurol Sci 2013;40:307-323). The publication updates recommendations published in 2004 (Freedman et al. Can J Neurol Sci 2004;31:157-168). See below for free download information. Subscribe to read more It takes 30 seconds or login using your email address Please enter the email address that you registered the newsletter with Continue…
…ersity of British Columbia study is one of the first to report on birth outcomes in fathers with MS (Lu et al. ENS 2013). The retrospective study examined data from several provincial databases to compare babies born to men with and without MS. For the period 1996-2010, a total of 202 births to fathers with MS and 981 births to fathers without MS were identified. No significant differences were observed in gestation (39 weeks) or mean birth weight…
…lerosis Migraine Vestibular disorders Stroke Amyotrophic lateral sclerosis Comment by Dr. Daniel Selchen, Toronto, Canada Multiple sclerosis: An analysis of long-term data from the PRISMS study of IFNbeta-1a indicates that baseline EDSS score and a change in EDSS from baseline to month 24 of treatment strongly predict outcomes at 15-year follow-up (Kappos et al. ENS 2013). Conclusions were based on follow-up of 291 subjects of the 560 patients (52…
…onsible nor liable for any errors or omissions that may be found in such information or for the results obtained from the use of such information. You are encouraged to consult other sources and confirm the information contained in any of the services or pages accessible within or from NeuroSens, or any other Lind Publishing service or publication. If erroneous or otherwise inaccurate information is brought to our attention, a reasonable effort wi…
…An analysis of an Ontario claims database shows that a small proportion of neurologists prescribe most of the disease-modifying therapies (DMTs) for MS (Marriott et al. Can J Neurol Sci 2013;40:67-72). Overall, 80% of DMT prescriptions were written by 12% of the neurologist community. Subscribe to read more It takes 30 seconds or login using your email address Please enter the email address that you registered the newsletter with Continue…